Panel Of 20 Proteins In Blood May Be Used To Quantify Disease Activity In People With MS, Study Proposes

Multiple Sclerosis News Today (7/5, Wexler) reported, “A panel of 20 proteins in blood may be used to quantify disease activity, namely relapses and lesions, in people with multiple sclerosis (MS), a new paper proposes.” The researchers said, “A multi-protein panel like the one developed in this study has the capability to capture the state of a patient’s MS from multiple angles, allowing for a fuller picture of their pathophysiology [disease biology].” The findings were published in Nature Communications.